TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs17819300
log Bayes Factor = 0.0898622
Chromosome 15   position 56,210,929  (GRCh37) Explore rs17819300 on Ensembl!
Variant rs17819300 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M16.1 Other primary coxarthrosis
0.000 0.898 0.102
Y43.3 Other antineoplastic drugs
0.000 0.905 0.095
N94.1 Dyspareunia
0.072 0.928 0.000
N94.6 Dysmenorrhoea, unspecified
0.071 0.929 0.000
Y43 Primarily systemic agents
0.000 0.929 0.071
N94 Pain and other conditions associated with female genital organs and menstrual cycle
0.070 0.930 0.000
N94.3 Premenstrual tension syndrome
0.063 0.937 0.000
Y43.4 Immunosuppressive agents
0.000 0.939 0.061
N94.4 Primary dysmenorrhoea
0.059 0.941 0.000
Y43.0 Antiallergic and antiemetic drugs
0.000 0.943 0.057
Y43.1 Antineoplastic antimetabolites
0.000 0.945 0.055
Y43.9 Primarily systemic agent, unspecified
0.000 0.949 0.051
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.949 0.051
Y43.6 Enzymes, not elsewhere classified
0.000 0.949 0.051
Y43.5 Acidifying and alkalising agents
0.000 0.949 0.051
Y43.2 Antineoplastic natural products
0.000 0.949 0.051
N94.9 Unspecified condition associated with female genital organs and menstrual cycle
0.051 0.949 0.000
N94.2 Vaginismus
0.050 0.950 0.000
N94.0 Mittelschmerz
0.050 0.950 0.000
N94.5 Secondary dysmenorrhoea
0.047 0.952 0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities
0.000 0.973 0.027
N94.8 Other specified conditions associated with female genital organs and menstrual cycle
0.026 0.974 0.000
N92.6 Irregular menstruation, unspecified
0.017 0.983 0.000
Y45.1 Salicylates
0.000 0.988 0.012
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.989 0.011
Y45.0 Opioids and related analgesics
0.000 0.990 0.010
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.990 0.010
R56.8 Other and unspecified convulsions
0.000 0.990 0.010
Y45.2 Propionic acid derivatives
0.000 0.991 0.009
H72.9 Perforation of tympanic membrane, unspecified
0.009 0.991 0.000
Y45.8 Other analgesics and antipyretics
0.000 0.991 0.008
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.992 0.008
Y45.4 Antirheumatics
0.000 0.992 0.008
I80.1 Phlebitis and thrombophlebitis of femoral vein
0.000 0.992 0.008
I80 Phlebitis and thrombophlebitis
0.000 0.992 0.008
H72 Perforation of tympanic membrane
0.008 0.992 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.992 0.008
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.992 0.008
H71 Cholesteatoma of middle ear
0.008 0.992 0.000
M75.4 Impingement syndrome of shoulder
0.000 0.993 0.007
Y58 Bacterial vaccines
0.000 0.993 0.007
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.993 0.007
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.993 0.007
H65-H75 Diseases of middle ear and mastoid
0.007 0.993 0.000
Y45.5 4-Aminophenol derivatives
0.000 0.993 0.007
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.993 0.007
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.993 0.007
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.993 0.007
Y48 Anaesthetics and therapeutic gases
0.000 0.993 0.007
H66.3 Other chronic suppurative otitis media
0.007 0.993 0.000
H66 Suppurative and unspecified otitis media
0.007 0.993 0.000
Y59 Other and unspecified vaccines and biological substances
0.000 0.993 0.007
H72.1 Attic perforation of tympanic membrane
0.007 0.993 0.000
Y57 Other and unspecified drugs and medicaments
0.000 0.993 0.006
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.993 0.006
H72.2 Other marginal perforations of tympanic membrane
0.006 0.994 0.000
H72.8 Other perforations of tympanic membrane
0.006 0.994 0.000
B37.8 Candidiasis of other sites
0.000 0.994 0.006
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.994 0.006
Z53.0 Procedure not carried out because of contraindication
0.000 0.994 0.006
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.994 0.006
Y41.5 Antiviral drugs
0.000 0.994 0.006
Y41.4 Anthelminthics
0.000 0.994 0.006
Y41.3 Other antiprotozoal drugs
0.000 0.994 0.006
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.994 0.006
Y41.1 Antimycobacterial drugs
0.000 0.994 0.006
Y41.0 Sulphonamides
0.000 0.994 0.006
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.994 0.006
Y52 Agents primarily affecting the cardiovascular system
0.000 0.994 0.006
H69 Other disorders of Eustachian tube
0.006 0.994 0.000
H66.4 Suppurative otitis media, unspecified
0.006 0.994 0.000
H73 Other disorders of tympanic membrane
0.006 0.994 0.000
Y49.5 Other antipsychotics and neuroleptics
0.000 0.994 0.006
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.994 0.005
R05 Cough
0.000 0.994 0.006
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.994 0.005
N30.8 Other cystitis
0.006 0.994 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.005 0.994 0.000
H70 Mastoiditis and related conditions
0.005 0.994 0.000
Y48.3 Local anaesthetics
0.000 0.995 0.005
Y50.9 Central nervous system stimulant, unspecified
0.000 0.995 0.005
Y50.8 Other central nervous system stimulants
0.000 0.995 0.005
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.995 0.005
Y50.1 Opioid receptor antagonists
0.000 0.995 0.005
Y50.0 Analeptics
0.000 0.995 0.005
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.995 0.005
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.995 0.005
Y55.5 Anticommon cold drugs
0.000 0.995 0.005
Y55.4 Expectorants
0.000 0.995 0.005
Y55.3 Antitussives
0.000 0.995 0.005
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.995 0.005
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.995 0.005
Y55.0 Oxytocic drugs
0.000 0.995 0.005
Y58.9 Other and unspecified bacterial vaccines
0.000 0.995 0.005
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.995 0.005
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.995 0.005
Y58.5 Diphtheria vaccine
0.000 0.995 0.005
Y58.4 Tetanus vaccine
0.000 0.995 0.005
Y58.3 Plague vaccine
0.000 0.995 0.005
Y58.2 Cholera vaccine
0.000 0.995 0.005
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.995 0.005
Y58.0 BCG vaccine
0.000 0.995 0.005
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.005 0.995 0.000
H68 Eustachian salpingitis and obstruction
0.005 0.995 0.000
H67 Otitis media in diseases classified elsewhere
0.005 0.995 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.995 0.005
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.995 0.005
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.995 0.005
Y47.4 Bromine compounds
0.000 0.995 0.005
Y47.3 Paraldehyde
0.000 0.995 0.005
Y47.2 Chloral derivatives
0.000 0.995 0.005
Y47.0 Barbiturates, not elsewhere classified
0.000 0.995 0.005
Y44 Agents primarily affecting blood constituents
0.000 0.995 0.005
Y49.9 Psychotropic drug, unspecified
0.000 0.995 0.005
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
Y49.7 Psychostimulants with abuse potential
0.000 0.995 0.005
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.995 0.005
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.995 0.005
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.995 0.005
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.995 0.005
Y48.5 Therapeutic gases
0.000 0.995 0.005
Y48.2 Other and unspecified general anaesthetics
0.000 0.995 0.005
Y48.1 Parenteral anaesthetics
0.000 0.995 0.005
Y48.0 Inhaled anaesthetics
0.000 0.995 0.005
Y47.1 Benzodiazepines
0.000 0.995 0.005
H66.2 Chronic atticoantral suppurative otitis media
0.005 0.995 0.000
H66.0 Acute suppurative otitis media
0.005 0.995 0.000
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities
0.000 0.995 0.005
Y59.9 Vaccine or biological substance, unspecified
0.000 0.995 0.005
Y59.8 Other specified vaccines and biological substances
0.000 0.995 0.005
Y59.2 Protozoal vaccines
0.000 0.995 0.005
Y59.1 Rickettsial vaccines
0.000 0.995 0.005
Y59.0 Viral vaccines
0.000 0.995 0.005
Y57.9 Drug or medicament, unspecified
0.000 0.995 0.005
N81.5 Vaginal enterocele
0.000 0.995 0.005
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.995 0.005
H72.0 Central perforation of tympanic membrane
0.005 0.995 0.000
Y57.8 Other drugs and medicaments
0.000 0.995 0.005
Y57.7 Vitamins, not elsewhere classified
0.000 0.995 0.005
Y57.6 Other diagnostic agents
0.000 0.995 0.005
Y57.4 Pharmaceutical excipients
0.000 0.995 0.005
Y57.3 Alcohol deterrents
0.000 0.995 0.005
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.995 0.005
Y57.1 Lipotropic drugs
0.000 0.995 0.005
Y57.0 Appetite depressants [anorectics]
0.000 0.995 0.005
Y56.9 Topical agent, unspecified
0.000 0.995 0.005
Y56.8 Other topical agents
0.000 0.995 0.005
Y56.7 Dental drugs, topically applied
0.000 0.995 0.005
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.995 0.005
Y56.5 Ophthalmological drugs and preparations
0.000 0.995 0.005
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.995 0.005
Y56.3 Emollients, demulcents and protectants
0.000 0.995 0.005
Y56.2 Local astringents and local detergents
0.000 0.995 0.005
Y56.1 Antipruritics
0.000 0.995 0.005
H73.9 Disorder of tympanic membrane, unspecified
0.005 0.995 0.000
Y48.4 Anaesthetic, unspecified
0.000 0.995 0.005
Y40 Systemic antibiotics
0.000 0.995 0.005
H74 Other disorders of middle ear and mastoid
0.005 0.995 0.000
H69.9 Eustachian tube disorder, unspecified
0.005 0.995 0.000
I80.8 Phlebitis and thrombophlebitis of other sites
0.000 0.995 0.005
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.995 0.005
Y46.8 Antispasticity drugs
0.000 0.995 0.004
Y46.7 Anti-Parkinsonism drugs
0.000 0.995 0.004
Y46.6 Other and unspecified antiepileptics
0.000 0.995 0.004
Y46.5 Valproic acid
0.000 0.995 0.004
Y46.3 Deoxybarbiturates
0.000 0.995 0.004
Y46.2 Hydantoin derivatives
0.000 0.995 0.004
Y46.1 Oxazolidinediones
0.000 0.995 0.004
Y46.0 Succinimides
0.000 0.995 0.004
Y59.3 Immunoglobulin
0.000 0.995 0.004
Y49.2 Other and unspecified antidepressants
0.000 0.995 0.004
H69.8 Other specified disorders of Eustachian tube
0.004 0.995 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.995 0.004
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.995 0.004
Y53.7 Emetics
0.000 0.995 0.004
Y53.6 Antidiarrhoeal drugs
0.000 0.995 0.004
Y53.5 Digestants
0.000 0.995 0.004
Y53.3 Saline and osmotic laxatives
0.000 0.995 0.004
Y53.2 Stimulant laxatives
0.000 0.995 0.004
Y53.0 Histamine H2-receptor antagonists
0.000 0.995 0.004
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.995 0.004
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.995 0.004
Y52.7 Peripheral vasodilators
0.000 0.995 0.004
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.995 0.004
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.995 0.004
B37.9 Candidiasis, unspecified
0.000 0.995 0.004
H69.0 Patulous Eustachian tube
0.004 0.995 0.000
H73.1 Chronic myringitis
0.004 0.995 0.000
H73.0 Acute myringitis
0.004 0.995 0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site
0.000 0.995 0.004
Y53.4 Other laxatives
0.000 0.996 0.004
H73.8 Other specified disorders of tympanic membrane
0.004 0.996 0.000
Y52.1 Calcium-channel blockers
0.000 0.996 0.004
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.996 0.004
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.996 0.004
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.996 0.004
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.996 0.004
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.996 0.004
Y51.0 Anticholinesterase agents
0.000 0.996 0.004
Y54.9 Mineral salts, not elsewhere classified
0.000 0.996 0.004
Y54.8 Agents affecting uric acid metabolism
0.000 0.996 0.004
Y54.7 Agents affecting calcification
0.000 0.996 0.004
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.996 0.004
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.996 0.004
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.996 0.004
Y54.0 Mineralocorticoids
0.000 0.996 0.004
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.996 0.004
H70.9 Mastoiditis, unspecified
0.004 0.996 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.996 0.004
H70.8 Other mastoiditis and related conditions
0.004 0.996 0.000
H70.2 Petrositis
0.004 0.996 0.000
H70.1 Chronic mastoiditis
0.004 0.996 0.000
H70.0 Acute mastoiditis
0.004 0.996 0.000
B37 Candidiasis
0.000 0.996 0.004
T93.2 Sequelae of other fractures of lower limb
0.004 0.996 0.000
H67.8 Otitis media in other diseases classified elsewhere
0.004 0.996 0.000
H67.1 Otitis media in viral diseases classified elsewhere
0.004 0.996 0.000
H67.0 Otitis media in bacterial diseases classified elsewhere
0.004 0.996 0.000
H68.1 Obstruction of Eustachian tube
0.004 0.996 0.000
H68.0 Eustachian salpingitis
0.004 0.996 0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.004 0.996 0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.004 0.996 0.000
Y57.5 X-ray contrast media
0.000 0.996 0.004
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.996 0.004
C50.8 Overlapping lesion of breast
0.000 0.996 0.004
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.996 0.004
Y44.7 Plasma substitutes
0.000 0.996 0.004
Y44.6 Natural blood and blood products
0.000 0.996 0.004
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.996 0.004
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.996 0.004
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.996 0.004
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.996 0.004
Y54.5 Other diuretics
0.000 0.996 0.004
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified
0.000 0.996 0.004
R56 Convulsions, not elsewhere classified
0.000 0.996 0.004
H74.1 Adhesive middle ear disease
0.004 0.996 0.000
Y54.4 Loop [high-ceiling] diuretics
0.000 0.996 0.004
E21.0 Primary hyperparathyroidism
0.000 0.996 0.004
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.996 0.004
Y46.4 Iminostilbenes
0.000 0.996 0.003
Y42.9 Other and unspecified hormone antagonists
0.000 0.996 0.004
Y42.4 Oral contraceptives
0.000 0.996 0.004
Y42.2 Antithyroid drugs
0.000 0.996 0.004
Y42.1 Thyroid hormones and substitutes
0.000 0.996 0.004
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.996 0.004
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.996 0.004
H66.9 Otitis media, unspecified
0.004 0.996 0.000
Y40.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
Y40.6 Rifamycins
0.000 0.996 0.004
Y40.5 Aminoglycosides
0.000 0.996 0.004
Y40.4 Tetracyclines
0.000 0.996 0.004
Y40.2 Chloramphenicol group
0.000 0.996 0.004
H74.2 Discontinuity and dislocation of ear ossicles
0.004 0.996 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.996 0.003
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.004 0.996 0.000
H74.4 Polyp of middle ear
0.004 0.996 0.000
H74.0 Tympanosclerosis
0.004 0.996 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.996 0.004
H74.9 Disorder of middle ear and mastoid, unspecified
0.004 0.996 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.996 0.004
H74.3 Other acquired abnormalities of ear ossicles
0.004 0.996 0.000
Y40.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
Y44.5 Thrombolytic drugs
0.000 0.996 0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.996 0.003
Y40.0 Penicillins
0.000 0.997 0.003
Y42.5 Other oestrogens and progestogens
0.000 0.997 0.003
M75 Shoulder lesions
0.000 0.997 0.003
M75.2 Bicipital tendinitis
0.000 0.997 0.003
Y40.3 Macrolides
0.000 0.997 0.003
Y53.1 Other antacids and anti-gastric-secretion drugs
0.001 0.997 0.003
Y54.3 Benzothiadiazine derivatives
0.000 0.997 0.003
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.997 0.003
B37.7 Candidal septicaemia
0.000 0.997 0.003
B37.6 Candidal endocarditis
0.000 0.997 0.003
B37.5 Candidal meningitis
0.000 0.997 0.003
B37.4 Candidiasis of other urogenital sites
0.000 0.997 0.003
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.000 0.997 0.003
B37.1 Pulmonary candidiasis
0.000 0.997 0.003
R56.0 Febrile convulsions
0.000 0.997 0.003
Y42.7 Androgens and anabolic congeners
0.000 0.997 0.003
M16 Coxarthrosis [arthrosis of hip]
0.000 0.997 0.003
S42.30 Fracture of shaft of humerus (closed)
0.003 0.997 0.000
Y44.2 Anticoagulants
0.000 0.997 0.003
B37.2 Candidiasis of skin and nail
0.000 0.997 0.003
H74.8 Other specified disorders of middle ear and mastoid
0.003 0.997 0.000
N87.0 Mild cervical dysplasia
0.003 0.997 0.000
Y85.0 Sequelae of motor-vehicle accident
0.003 0.997 0.000
Y40.8 Other systemic antibiotics
0.000 0.997 0.003
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.997 0.003
G40.9 Epilepsy, unspecified
0.000 0.997 0.003
S42.3 Fracture of shaft of humerus
0.003 0.997 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.997 0.003
B37.3 Candidiasis of vulva and vagina
0.000 0.997 0.003
M75.8 Other shoulder lesions
0.000 0.997 0.003
D68.5 Primary Thrombophilia
0.003 0.997 0.000
M75.3 Calcific tendinitis of shoulder
0.000 0.997 0.003
S42.20 Fracture of upper end of humerus (closed)
0.003 0.997 0.000
M16.3 Other dysplastic coxarthrosis
0.000 0.997 0.003
S42 Fracture of shoulder and upper arm
0.003 0.997 0.000
S42.2 Fracture of upper end of humerus
0.003 0.997 0.000
T93 Sequelae of injuries of lower limb
0.003 0.997 0.000
S82.60 Fracture of lateral malleolus (closed)
0.003 0.997 0.000
T93.0 Sequelae of open wound of lower limb
0.003 0.997 0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]
0.000 0.997 0.003
M75.9 Shoulder lesion, unspecified
0.000 0.997 0.002
B37.0 Candidal stomatitis
0.000 0.997 0.003
M16.6 Other secondary coxarthrosis, bilateral
0.000 0.997 0.002
M16.4 Posttraumatic coxarthrosis, bilateral
0.000 0.997 0.002
S42.1 Fracture of scapula
0.002 0.997 0.000
S42.10 Fracture of scapula (closed)
0.002 0.998 0.000
Z01.6 Radiological examination, not elsewhere classified
0.000 0.998 0.002
S82.10 Fracture of upper end of tibia (closed)
0.002 0.998 0.000
T93.8 Sequelae of other specified injuries of lower limb
0.002 0.998 0.000
S42.9 Fracture of shoulder girdle, part unspecified
0.002 0.998 0.000
Y85.9 Sequelae of other and unspecified transport accidents
0.002 0.998 0.000
S42.31 Fracture of shaft of humerus (open)
0.002 0.998 0.000
E87.5 Hyperkalaemia
0.002 0.998 0.000
S82.20 Fracture of shaft of tibia (closed)
0.002 0.998 0.000
K76.6 Portal hypertension
0.000 0.998 0.002
S32.50 Fracture of pubis (closed)
0.000 0.998 0.002
E28.2 Polycystic ovarian syndrome
0.000 0.998 0.002
Y85 Sequelae of transport accidents
0.002 0.998 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.998 0.002
E21.4 Other specified disorders of parathyroid gland
0.000 0.998 0.002
E21.2 Other hyperparathyroidism
0.000 0.998 0.002
M75.81 Other shoulder lesions, right shoulder
0.000 0.998 0.002
E21.3 Hyperparathyroidism, unspecified
0.000 0.998 0.002
M75.1 Rotator cuff syndrome
0.000 0.998 0.002
S42.4 Fracture of lower end of humerus
0.002 0.998 0.000
T93.1 Sequelae of fracture of femur
0.002 0.998 0.000
M75.0 Adhesive capsulitis of shoulder
0.000 0.998 0.002
S82.2 Fracture of shaft of tibia
0.002 0.998 0.000
M54.99 Dorsalgia, unspecified (Site unspecified)
0.000 0.998 0.002
S82.21 Fracture of shaft of tibia (open)
0.002 0.998 0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral
0.000 0.998 0.002
H93.1 Tinnitus
0.000 0.998 0.002
S42.8 Fracture of other parts of shoulder and upper arm
0.002 0.998 0.000
S42.7 Multiple fractures of clavicle, scapula and humerus
0.002 0.998 0.000
S82.6 Fracture of lateral malleolus
0.002 0.998 0.000
S42.21 Fracture of upper end of humerus (open)
0.002 0.998 0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.002 0.998 0.000
T93.4 Sequelae of injury of nerve of lower limb
0.002 0.998 0.000
D68.2 Hereditary deficiency of other clotting factors
0.002 0.998 0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.002 0.998 0.000
E28 Ovarian dysfunction
0.000 0.998 0.002
H65 Nonsuppurative otitis media
0.002 0.998 0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec
0.000 0.998 0.002
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other
0.000 0.998 0.002
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot
0.000 0.998 0.002
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg
0.000 0.998 0.002
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh
0.000 0.998 0.002
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm
0.000 0.998 0.002
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm
0.000 0.998 0.002
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region
0.000 0.998 0.002
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites
0.000 0.998 0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.998 0.002
E23.0 Hypopituitarism
0.000 0.998 0.002
S42.90 Fracture of shoulder girdle, part unspecified (closed)
0.002 0.998 0.000
S82.1 Fracture of upper end of tibia
0.002 0.998 0.000
S42.11 Fracture of scapula (open)
0.002 0.998 0.000
M16.5 Other posttraumatic coxarthrosis
0.000 0.998 0.002
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.000 0.998 0.002
M72 Fibroblastic disorders
0.000 0.998 0.002
S42.0 Fracture of clavicle
0.002 0.998 0.000
E24.9 Cushing's syndrome, unspecified
0.000 0.998 0.002
B35-B49 Mycoses
0.000 0.998 0.002
M47.92 Spondylosis, unspecified (Cervical region)
0.002 0.998 0.000
E23 Hypofunction and other disorders of pituitary gland
0.000 0.998 0.002
E20-E35 Disorders of other endocrine glands
0.000 0.998 0.002
T93.3 Sequelae of dislocation, sprain and strain of lower limb
0.002 0.998 0.000
E24 Cushing's syndrome
0.000 0.998 0.002
S42.91 Fracture of shoulder girdle, part unspecified (open)
0.002 0.998 0.000
S42.40 Fracture of lower end of humerus (closed)
0.002 0.998 0.000
L85.8 Other specified epidermal thickening
0.000 0.998 0.002
J85.2 Abscess of lung without pneumonia
0.002 0.998 0.000
B49 Unspecified mycosis
0.000 0.998 0.002
S42.41 Fracture of lower end of humerus (open)
0.002 0.998 0.000
M16.7 Other secondary coxarthrosis
0.000 0.998 0.002
S40.0 Contusion of shoulder and upper arm
0.002 0.998 0.000
S42.71 Multiple fractures of clavicle, scapula and humerus (open)
0.002 0.998 0.000
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)
0.002 0.998 0.000
S42.81 Fracture of other parts of shoulder and upper arm (open)
0.002 0.998 0.000
S42.80 Fracture of other parts of shoulder and upper arm (closed)
0.002 0.998 0.000
M75.5 Bursitis of shoulder
0.000 0.998 0.002
S82.61 Fracture of lateral malleolus (open)
0.002 0.998 0.000
E28.3 Primary ovarian failure
0.000 0.998 0.002
M43.1 Spondylolisthesis
0.000 0.998 0.002
E23.2 Diabetes insipidus
0.000 0.998 0.002
C73 Malignant neoplasm of thyroid gland
0.000 0.998 0.002
S82 Fracture of lower leg, including ankle
0.002 0.998 0.000
E28.9 Ovarian dysfunction, unspecified
0.000 0.998 0.002
E28.8 Other ovarian dysfunction
0.000 0.998 0.002
E28.1 Androgen excess
0.000 0.998 0.002
E28.0 Oestrogen excess
0.000 0.998 0.002
H65.1 Other acute nonsuppurative otitis media
0.002 0.998 0.000
H65.0 Acute serous otitis media
0.002 0.998 0.000
R50.9 Fever, unspecified
0.000 0.998 0.002
E22 Hyperfunction of pituitary gland
0.000 0.998 0.002
S82.11 Fracture of upper end of tibia (open)
0.002 0.998 0.000
S82.3 Fracture of lower end of tibia
0.002 0.998 0.000
M72.9 Fibroblastic disorder, unspecified
0.000 0.998 0.002
M72.8 Other fibroblastic disorders
0.000 0.998 0.002
M72.6 Necrotizing fasciitis
0.000 0.998 0.002
M72.5 Fasciitis, not elsewhere classified
0.000 0.998 0.002
M72.4 Pseudosarcomatous fibromatosis
0.000 0.998 0.002
M72.3 Nodular fasciitis
0.000 0.998 0.002
M72.1 Knuckle pads
0.000 0.998 0.002
S00.8 Superficial injury of other parts of head
0.002 0.998 0.000
S42.01 Fracture of clavicle (open)
0.002 0.998 0.000
G30.9 Alzheimer's disease, unspecified
0.000 0.998 0.002
E20 Hypoparathyroidism
0.000 0.998 0.002
M70-M79 Other soft tissue disorders
0.000 0.998 0.002
B48 Other mycoses, not elsewhere classified
0.000 0.998 0.002
B47 Mycetoma
0.000 0.998 0.002
B46 Zygomycosis
0.000 0.998 0.002
B45 Cryptococcosis
0.000 0.998 0.002
B43 Chromomycosis and phaeomycotic abscess
0.000 0.998 0.002
B42 Sporotrichosis
0.000 0.998 0.002
B41 Paracoccidioidomycosis
0.000 0.998 0.002
B40 Blastomycosis
0.000 0.998 0.002
B39 Histoplasmosis
0.000 0.998 0.002
B38 Coccidioidomycosis
0.000 0.998 0.002
B36 Other superficial mycoses
0.000 0.998 0.002
S82.31 Fracture of lower end of tibia (open)
0.002 0.998 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.998 0.002
E23.1 Drug-induced hypopituitarism
0.000 0.998 0.002
E24.8 Other Cushing's syndrome
0.000 0.998 0.002
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.998 0.002
E24.3 Ectopic ACTH syndrome
0.000 0.998 0.002
E24.2 Drug-induced Cushing's syndrome
0.000 0.998 0.002
E24.1 Nelson's syndrome
0.000 0.998 0.002
E24.0 Pituitary-dependent Cushing's disease
0.000 0.998 0.002
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.998 0.002
E32 Diseases of thymus
0.000 0.998 0.002
E31 Polyglandular dysfunction
0.000 0.998 0.002
E30 Disorders of puberty, not elsewhere classified
0.000 0.998 0.002
E25 Adrenogenital disorders
0.000 0.998 0.002
M70 Soft tissue disorders related to use, overuse and pressure
0.000 0.998 0.002
E22.1 Hyperprolactinaemia
0.000 0.998 0.002
N87.1 Moderate cervical dysplasia
0.002 0.998 0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)
0.002 0.998 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
0.002 0.998 0.000
M72.2 Plantar fascial fibromatosis
0.000 0.998 0.001
T88.4 Failed or difficult intubation
0.002 0.998 0.000
E23.6 Other disorders of pituitary gland
0.000 0.998 0.001
H65.2 Chronic serous otitis media
0.001 0.998 0.000
N41.1 Chronic prostatitis
0.002 0.998 0.000
B35 Dermatophytosis
0.000 0.998 0.002
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.000 0.998 0.001
M43.15 Spondylolisthesis (Thoracolumbar region)
0.000 0.998 0.001
M43.14 Spondylolisthesis (Thoracic region)
0.000 0.998 0.001
M43.13 Spondylolisthesis (Cervicothoracic region)
0.000 0.998 0.001
M43.12 Spondylolisthesis (Cervical region)
0.000 0.998 0.001
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.000 0.998 0.001
M43.10 Spondylolisthesis (Multiple sites in spine)
0.000 0.998 0.001
S82.30 Fracture of lower end of tibia (closed)
0.002 0.998 0.000
T93.9 Sequelae of unspecified injury of lower limb
0.001 0.998 0.000
Z35.5 Supervision of elderly primigravida
0.000 0.998 0.002
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.998 0.001
E22.8 Other hyperfunction of pituitary gland
0.000 0.998 0.001
M70.2 Olecranon bursitis
0.000 0.998 0.001
S82.9 Fracture of lower leg, part unspecified
0.001 0.998 0.000
S82.7 Multiple fractures of lower leg
0.001 0.998 0.000
S82.4 Fracture of fibula alone
0.002 0.998 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.998 0.001
E22.0 Acromegaly and pituitary gigantism
0.000 0.998 0.001
S32.5 Fracture of pubis
0.000 0.998 0.002
E34 Other endocrine disorders
0.000 0.998 0.001
B44 Aspergillosis
0.000 0.998 0.001
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.998 0.001
M72.19 Knuckle pads (Site unspecified)
0.000 0.998 0.001
M72.18 Knuckle pads-Other
0.000 0.998 0.001
M72.17 Knuckle pads (Ankle and foot)
0.000 0.998 0.001
M72.16 Knuckle pads-Lower Leg
0.000 0.998 0.001
M72.15 Knuckle pads-Pelvic/Thigh
0.000 0.998 0.001
M72.14 Knuckle pads (Hand)
0.000 0.998 0.001
M72.13 Knuckle pads-Forearm
0.000 0.998 0.001
M72.12 Knuckle pads-Upper arm
0.000 0.998 0.001
M72.11 Knuckle pads-Shldr region
0.000 0.998 0.001
M72.10 Knuckle pads (Multiple sites)
0.000 0.998 0.001
M72.39 Nodular fasciitis-Site unspec
0.000 0.998 0.001
M72.38 Nodular fasciitis-Other
0.000 0.998 0.001
M72.37 Nodular fasciitis-Ankle/Foot
0.000 0.998 0.001
M72.36 Nodular fasciitis-Lower Leg
0.000 0.998 0.001
M72.35 Nodular fasciitis-Pelvic/Thigh
0.000 0.998 0.001
M72.34 Nodular fasciitis-Hand
0.000 0.998 0.001
M72.33 Nodular fasciitis-Forearm
0.000 0.998 0.001
M72.32 Nodular fasciitis-Upper arm
0.000 0.998 0.001
M72.31 Nodular fasciitis-Shldr region
0.000 0.998 0.001
M72.30 Nodular fasciitis-Mult sites
0.000 0.998 0.001
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)
0.000 0.998 0.001
M72.48 Pseudosarcomatous fibromatosis (Other)
0.000 0.998 0.001
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)
0.000 0.998 0.001
M72.46 Pseudosarcomatous fibromatosis (Lower leg)
0.000 0.998 0.001
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)
0.000 0.998 0.001
M72.44 Pseudosarcomatous fibromatosis (Hand)
0.000 0.998 0.001
M72.43 Pseudosarcomatous fibromatosis (Forearm)
0.000 0.998 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.